In a piece for investing blog Seeking Alpha, contributor Sarah Maller discusses her reasons for giving up on health care giant Johnson & Johnson as a viable investment.
“Manufacturing problems and recalls are not just embarrassing,” she writes, “but they are a worrisome sign that management has taken its eye off the ball in many key respects.”
Maller specifically mentions a recall that Johnson & Johnson initiated for its LPS Diaphyseal Sleeve, ...
continue reading...